Nebula Biotechnology Co., Ltd..

+86-15801534258
info@nebulabio.cn
Product Name NebuSelect™ Recombinant Human PLA2G7, His-tag
Catalog Number NBL-242192
Alias/Synonyms PLA2G7; LDL-PLA2; PAFAD; PAFAH
Appearance see COA
Molecule Weight Phe22-Asn441
CAS N/A
Solubility Water Soluble
Storage Short term 4℃; Long term -20℃.
Shelf Life 2 years
Additional info 1 Q13093
Additional info 2
Catalog Numbe Size Price Inventory Level  
NBL-242192-100ug 100ug Inquire Inquire
NBL-242192-1mg 1mg Inquire Inquire
NBL-242192-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human PLA2G7, His-tag


Catalog#:

NBL-242192


Description:

NebuSelect™ Recombinant Human PLA2G7, His-tag(Cat#NBL-242192) is expressed in HEK293 with His tag at the C-Terminus.It contains Phe22-Asn441.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 48.9 kDa. Due to glycosylation, the protein migrates to 49-60 kDa based on Bis-Tris PAGE result.


Target Name:

PLA2G7; LDL-PLA2; PAFAD; PAFAH


Target Information:

Endogenous PLA2G7 transcription levels were found to be significantly lower in vascular related cell lines than in the other cell lines. Luciferase reporter gene assays indicated that gene activity was significantly enhanced by PLA2G7 promoter fragment. LA2G7 transcription was found to be up-regulated with the treatment of DAC. The 17-β-estradiol was found to down-regulate PLA2G7 transcription in all the cell lines.


Amino Acid Sequence: 

Phe22-Asn441


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

Top-selling Items